Research Administration

Leigh Goodson, Ph.D.

Vice President for Research and Institutional Advancement, OSU in Tulsa
Associate Professor of Osteopathic Manipulative Medicine
918-561-1406
leigh.goodson@okstate.edu

• Oversees and coordinates operations
• Liaison to federal, state and local elected officials and public agencies to track legislative issues that involve the campus and higher education

Dr. Leigh B. Goodson is Vice President for Research and Institutional Advancement and School Head/Associate Professor, Health Care Administration at OSU Tulsa and OSU Center for Health Sciences. As vice president for research, Leigh oversees the functioning of the Office of Research and Sponsored Programs. Leigh works closely with the OSU administration through government relations and works to foster relationships with state and national legislators. As an active member of the community Leigh serves on the Tulsa Public Schools Board of Education, board of the YMCA of Greater Tulsa Metro Board of Directors, YMCA Camp Takatoka Advisory Board, and is also a parent volunteer for Tulsa Public Schools.. Leigh is a “graduate” of Leadership Oklahoma class of 2010 and Leadership Tulsa. She has a Ph.D. in Educational Research and a BA in Political Science from OSU Stillwater, OK and an MS in Organizational Communication from Fort Hays University, Fort Hays, Kansas. Leigh is a native of Tulsa, OK. Leigh is married to Mark Goodson and they have two children.

Johnny Stephens, Pharm.D.

Associate Professor, Department of Internal Medicine
Assistant Dean of Sponsored Programs, OSU Center for Health Sciences
918-382-5058
johnny.stephens@okstate.edu

• Oversees the clinical trials office
• Oversees CAHM

  Dr. Johnny R. Stephens completed his Doctorate in Pharmacy and Fellowship in Infectious Diseases at the University of Oklahoma College of Pharmacy (OU-COP).  Research and education has been a priority since the completion of his fellowship at OU-COP.  He has been very fortunate to work collaboratively with many capable faculty on clinical trials as well as writing manuscripts.  Johnny has continued to evolve his role in research to include residents and students into the process.  His research has been varied to include prospective investigator initiated trials, prospective clinical trials, retrospective studies, case-control studies, case reports, literature reviews, and review articles.

  He has published articles in:  AIDS, The AIDS Reader, Baylor University Medical Center Proceedings, Hospital Pharmacy, Journal of the American Pharmaceutical Association, Infectious Diseases in Clinical Practice, Annals of Pharmacotherapy, Journal of the Oklahoma Osteophathic Association, and the Journal of the Oklahoma State Medical Association.  I have reviewed articles for Annals for Pharmacotherapy and Evidence Based Hospital Medicine. 

  The research and reviews he has participated in have been well represented at local, national, and international meetings.  Included in these presentations have been student and resident posters which he has helped learners gain exposure and experience in presenting on the national level.  Some of these meetings include:  American Society of Hospital Pharmacists (ASHP) Midyear Clinical Meeting, Western Region Pharmacy Student Research Conference, Conference on Retroviruses and Opportunistic Infections, First International Conference on Adherence to Antiretroviral Therapy, and the Society of Infectious Diseases Pharmacists (SIDP) Annual Meeting as well as several others. 

  Johnny’s clinical research started with participation in clinical trials with various researchers which continues today and has continued to evolve into a leadership position within both the Department of Internal Medicine as well as OSU-CHS.    Clinical trials research continues to be my most abundant contribution to research and has grown from participating in the research as a principal investigator to now helping guide the college of medicine in expanding this activity.

David R. Wallace, Ph.D.

Assistant Dean for Research, OSU Center for Health Sciences
Director of Regulatory Compliance, OSU Center for Health Sciences
918-561-1407
david.wallace@okstate.edu

• Advocacy for research at local, state and federal level
• Oversight and maintenance of research-related regulatory compliance issues
• Assist in award management
• Develop funding lines to support research infrastructure

Dr. Wallace joined Oklahoma State University Center for Health Sciences in 1996 after fellowships at the University of Kentucky and University of Colorado Health Science Center. Since his arrival, Dr. Wallace has been actively involved in teaching 2nd year medical students as well as graduate students in the Biomedical Science Program and the Forensic Science Program. Dr. Wallace has been extensively trained in basic pharmacological methods such as radioligand binding, neurotransmitter uptake/release and intracellular assays. The major foci and interests of the Wallace Laboratory are the excitatory mechanisms underlying neurotoxicity in the Central Nervous System.

Major Research Projects Underway:

• Project #1 examines the interaction between gp120/Tat (HIV proteins associated with neurotoxicity), estrogen, and cocaine in female rats. Ultimately, the goal of this research is to provide insight into gender-related differences in AIDS-related central nervous system disorders leading to potential gender-specific treatment strategies for HIV and cocaine addiction.
• Project #2 examines the effects of low-level heavy metal exposure on the dopaminergic function in cell culture and whole animal. Low-level exposure to heavy metals may not cause overt CNS effects until much later. These studies have implications in forensic analysis and determining the potential cause of CNS damage.  Of major concern is that low-level exposure may also lead to the development of particular diseases of the CNS such as Autism.  Current work is also focusing on alterations in dopaminergic function following exposure to environmental toxins, such as heavy metals.  We have observed significant social dysfunction in male voles following exposure to mercury.  Neurochemical studies in rats have demonstrated that the striatum is a dopamine-rich brain region which is robustly affected following exposure to mercury.  Additional work is being performed to correlate the outcomes observed in rat and vole studies and to further examine the neurochemical alterations following mercury exposure. 
• Project #3 investigates the use of naturally occurring compounds as centrally acting agents. One series of studies has been examining the effects of Native American plants indigenous to Oklahoma and their potential analgesic effects. A second series is investigating the estrogenic effects of flavonoids found in soy and flaxseed.  The ultimate goal of these studies is to identify novel compounds that may have therapeutic uses and to enter into entrepreneurial ventures to develop/market these agents.

Stanley E. Grogg, D.O., FACOP, FAAP

Professor of Pediatrics
Associate Dean of Clinical Research, OSU Center for Health Sciences
918-382-3146
stanley.grogg@okstate.edu

• Oversees vaccine and pediatric clinical trials

Stanley E. Grogg, DO, FACOP, FAAP, earned his Doctor of Osteopathy from the Kirksville College of Osteopathic Medicine. Dr. Grogg completed his pediatric residency at Oklahoma State University Medical Center. He was certified in pediatrics by the American Osteopathic Board of Pediatrics in 1978, and was awarded a Travel Medicine Certificate by the International Society of Travel Medicine (ISTM) in 2003. He is a fellow of the American Academy of Pediatrics and the American College of Osteopathic Pediatricians.

Dr. Grogg is a tenured Professor of Pediatrics, Associate Dean of Clinical Research, and the primary investigator for several clinical research studies at the OSU-CHS. He was the Oklahoma Osteopathic Association’s “Physician of the Year” in 2006 and the 2008 “Pediatrician of the Year” by the American College of Osteopathic Pediatricians. Stan has been an author and co-author of several published papers, abstracts and posters. He is the American Osteopathic Association’s liaison member of the CDC’s Advisory Committee on Immunization Practices (ACIP) and Vice-Chair of the Oklahoma Immunization Advisory Committee. In 2008, Dr. Grogg was awarded the Oklahoma State University-Center for Health Science’s Reagent Research Award. In 2011, Dr. Grogg was inducted into Phi Beta Delta Honor Society for International Scholars and most recently the recipient of an American Osteopathic Foundation’s Rossnick Humanitarian Grant and the 2011-12 OSU-CHS Faculty Distinguished Service Award.